These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32487555)

  • 1. Recurrent
    Tsigrelis C
    Cleve Clin J Med; 2020 Jun; 87(6):347-359. PubMed ID: 32487555
    [No Abstract]   [Full Text] [Related]  

  • 2. Strategies to prevent adverse outcomes following
    Rauseo AM; Olsen MA; Reske KA; Dubberke ER
    Expert Rev Anti Infect Ther; 2020 Mar; 18(3):203-217. PubMed ID: 31976779
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical management of severe, fulminant, and refractory
    Cheng YW; Fischer M
    Expert Rev Anti Infect Ther; 2020 Apr; 18(4):323-333. PubMed ID: 32057278
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
    Webb BJ; Subramanian A; Lopansri B; Goodman B; Jones PB; Ferraro J; Stenehjem E; Brown SM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964789
    [No Abstract]   [Full Text] [Related]  

  • 5. How to: prophylactic interventions for prevention of Clostridioides difficile infection.
    Reigadas E; van Prehn J; Falcone M; Fitzpatrick F; Vehreschild MJGT; Kuijper EJ; Bouza E;
    Clin Microbiol Infect; 2021 Dec; 27(12):1777-1783. PubMed ID: 34245901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in the Diagnosis and Management of Recurrent and Severe Clostridioides difficile Infection in Children.
    Sattler MM; Crews JD
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S27-S33. PubMed ID: 34791399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.
    Luo Y; Tixier EN; Grinspan AM
    Dig Dis Sci; 2020 Dec; 65(12):3647-3651. PubMed ID: 32078714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SER-109, an Oral Microbiome Therapy for Recurrent
    Feuerstadt P; Louie TJ; Lashner B; Wang EEL; Diao L; Bryant JA; Sims M; Kraft CS; Cohen SH; Berenson CS; Korman LY; Ford CB; Litcofsky KD; Lombardo MJ; Wortman JR; Wu H; Auniņš JG; McChalicher CWJ; Winkler JA; McGovern BH; Trucksis M; Henn MR; von Moltke L
    N Engl J Med; 2022 Jan; 386(3):220-229. PubMed ID: 35045228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic?
    Hawes AM; Desai A; Patel PK
    Anaerobe; 2021 Aug; 70():102384. PubMed ID: 34029702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiota restoration for recurrent Clostridioides difficile: Getting one step closer every day!
    Khanna S
    J Intern Med; 2021 Aug; 290(2):294-309. PubMed ID: 33856727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in the management of recurrent Clostridioides difficile infection.
    Mendo-Lopez R; Villafuerte-Gálvez J; White N; Mahoney MV; Kelly CP; Alonso CD
    Anaerobe; 2020 Apr; 62():102108. PubMed ID: 31606481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridioides difficile Infection in Children: The Role of Infection Prevention and Antimicrobial Stewardship.
    Savage TJ; Sandora TJ
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S64-S68. PubMed ID: 34791402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ridinilazole: a novel therapy for Clostridium difficile infection.
    Vickers RJ; Tillotson G; Goldstein EJ; Citron DM; Garey KW; Wilcox MH
    Int J Antimicrob Agents; 2016 Aug; 48(2):137-43. PubMed ID: 27283730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. World Society of Emergency Surgery-American Association for the Surgery of Trauma Guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients: An executive summary.
    Sartelli M; Ansaloni L; Biffl WA; Coccolini F; De Simone B; Leppaniemi A; Kluger Y; Tolonen M; Moore EE; Catena F
    J Trauma Acute Care Surg; 2021 Aug; 91(2):422-426. PubMed ID: 33783420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in
    Khanna S
    Expert Rev Anti Infect Ther; 2021 Sep; 19(9):1067-1070. PubMed ID: 33427531
    [No Abstract]   [Full Text] [Related]  

  • 16. A Review of Clostridioides difficile Infection and Antibiotic-Associated Diarrhea.
    Abad CLR; Safdar N
    Gastroenterol Clin North Am; 2021 Jun; 50(2):323-340. PubMed ID: 34024444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanisms and safety of probiotics against toxigenic
    Liu D; Zeng L; Yan Z; Jia J; Gao J; Wei Y
    Expert Rev Anti Infect Ther; 2020 Oct; 18(10):967-975. PubMed ID: 32520637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal microbiota transplantation for treatment of patients with recurrent
    Voth E; Khanna S
    Expert Rev Anti Infect Ther; 2020 Jul; 18(7):669-676. PubMed ID: 32266848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial stewardship program achieved marked decrease in Clostridium difficile infections in a Veterans Hospital.
    Morgan F; Belal M; Lisa B; Ford F; LeMaitre B; Psevdos G
    Am J Infect Control; 2020 Sep; 48(9):1119-1121. PubMed ID: 32035688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridioides difficile Infection: Update on Management.
    Mounsey A; Lacy Smith K; Reddy VC; Nickolich S
    Am Fam Physician; 2020 Feb; 101(3):168-175. PubMed ID: 32003951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.